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Functional, morphologic, and molecular
characterization of cold storage injury
Annette Ebner, PhD,a,b David M. Poitz, PhD,b Antje Augstein, PhD,b Ruth H. Strasser, MD, PhD,b and
Andreas Deussen, MD, PhD,a Dresden, Germany
Objective: Cold storage is used to preserve tissue for later transplantation. There is particular interest in prolonging cold
storage time for transplantation purposes. To date, the mechanisms that contribute to vascular dysfunction in response
to cold storage are poorly understood. The present study aims to characterize cold storage injury of blood vessels on
functional and molecular levels.
Methods: To assess vessel function of mouse aorta, isometric force measurements were performed in a Mulvany myograph
after cold storage at 4°C for various intervals. Morphologic changes were judged by histologic analysis of aortic
cross-sections. To characterize cold storage-induced alterations on RNA levels, microarray analysis with subsequent
polymerase chain reaction analysis was performed.
Results: Cold storage for 2 days revealed significant impairment of vessel function with respect to potassium-induced
vessel tone development and acetylcholine-induced vessel relaxation. Detailed analysis of acetylcholine-mediated vascular
response using specific pharmacologic blockers revealed that calcium-activated potassium channels seem to be impaired
after 2 days of cold storage. At this point, no severe histologic changes (eg, elastic fiber disruption) were visible. RNA
expression of 24 genes was significantly changed due to cold storage even after 2 hours. These include genes associated
with vessel tone development (prostaglandin E3 receptor), cardiovascular function (adiponectin), electron transport
chain (uncoupling protein 1), or calcium signaling (protein kinase A regulatory subunit 2b).
Conclusions: Long-term cold storage impairs vascular function, especially with respect to potassium signaling by
calcium-dependent potassium channels. Microarray analysis confirmed impairment of pathways that are involved in
calcium signaling and vascular function. Furthermore, various genes were significantly altered even after 2 hours,
significantly before functional impairment was observed. (J Vasc Surg 2012;56:189-98.)
Clinical Relevance: In bypass surgery, vessels are stored ex situ for <2 hours and for vessel banking for up to 48 hours
during decontamination before cryopreservation. We investigated the onset of storage-induced alterations. The experi-
ments reveal various genes were altered significantly, even within the first 2 hours of cold storage. This is of major
importance, because of the time delay between regulation of messenger RNA and protein level and functional
consequences. The alterations described here on the molecular level occur before any alterations on morphologic or
functional levels are obvious. These molecular alterations, however, may affect later graft function.
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DCold storage at 4°C is routinely performed for donor
tissues and organs for transplantation purposes during graft
transport from the donor to the recipient. Decreasing the
storage temperature can slow enzymatic activity of biologic
processes by 1.5-fold to 2-fold per each 10-K decrease in
temperature.1 However, sufficient tissue preservation oc-
curs only within a narrow interval. Hypothermic and isch-
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http://dx.doi.org/10.1016/j.jvs.2011.12.012mic injury2 contribute to cold storage injury as well as
ther tissue-specific phenomena, including adaptation to
owered shear stress for blood vessels.3
In the regular course of bypass graft surgery, vein and
rtery grafts are stored at room temperature for2 hours.4
owever, it could be reasonable to keep vessel segments of
atients with a desperate graft situation for later reimplan-
ation should early graft failure occur. Here, cold storage is
dvised. For later cryopreservation, grafts are usually stored
or 2 days while undergoing decontamination by antibiotic
reatment.5 Furthermore, isolated blood vessel allografts
re used for transplantation purposes, such as for infected
rtificial vascular grafts.6 Other uses may include allogenic
eplacement due to vessel stenosis in association with trans-
lantations. In addition, vascular grafts are used as conduits
or connecting the transplanted organ to the circulation
uch as in kidney or liver transplantation.
Maintenance of vessel function and, in particular, en-
othelial cell function seems important because endothelial
njury during storage may promote later vessel thrombosis
nd vessel wall inflammation7,8 and induce graft failure.
isturbance in vascular tone regulation is associated withn increased risk for clinical events.9
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July 2012190 Ebner et alThe aim of the present study was to identify cold
storage-associated alterations at the functional, morpho-
logic, and molecular level for future improvement of cold
storage conditions. In a first step, the time of onset of vessel
dysfunction for mouse aorta was determined, and pathways
participating in vascular function were characterized. In
addition to this functional characterization, microarray
analysis was performed to identify genes that are regulated
during cold storage. These targets may contribute to cold
storage injury or may participate in physiologic processes to
preserve the vessel. Mouse aorta was chosen as a model
because this tissue is well characterized with respect to
vessel function assays.
METHODS
Experiments involving animals were approved by the
University Commission on Animal Experiments with re-
spect to the animal welfare regulations of Germany, which
conform to the National Institutes of Health guidelines.
Written permission for the study was obtained from the
local authorities (24-9168.24-1/2009-19).
Animals and storage groups. Male C57Bl/6 mice
(Janvier, Le Genest Saint Isle, France) were euthanized by
carbon dioxide exposure. The thoracic aorta (without the
aortic arch) was harvested and directly placed in ice-cooled
TiProtec storage solution (Dr. F. Köhler GmbH, Ben-
sheim, Germany). Perivascular fat tissue was removed un-
der a binocular microscope. Absence of fat cells was
checked for each aorta at fourfold magnification, and spe-
cial care was taken that no fat cells remained at side
branches or the vessel rims. Up to four vessel segments of
approximately 2 mm were cut and stored for a minimum of
2 hours up to a maximum of 7 days at 4°C. Special care was
taken that all study groups contained proximal and distal
segments.
After cold storage at 4°C, vessel segments were trans-
ferred to prewarmed (37°C) phosphate-buffered saline so-
lution (containing 119 mmol/L NaCl; 4.7 mmol/L KCl;
1.17 mmol/L MgSO4; 1.18 mmol/L KH2PO4; 25
mmol/L NaHCO3; 5.5 mmol/L glucose; 0.027 mmol/L
ethylenediaminetetraacetic acid sodium salt; and 2.5
mmol/L CaCl2) and vessel tone was assessed by function
testing using isometric force measurement.
Isometric force measurement. Vessel function was
assessed according to the method of Mulvany and Halp-
ern,10 as described previously.11,12 Briefly, aortic rings
(712  7 m internal diameter) were studied in a myo-
graph (Power Lab/400, DMT-610M; ADInstruments,
GmbH, Spechbach, Germany) in which rings were
stretched with a resting tension equivalent to that obtained
by exposure to an intraluminal pressure of 20 mm Hg.
Maximum constriction was induced by exposure of vessel
rings to a potassium-enriched solution (123.7 mmol/L
KCl). For methodic reasons, two potassium stimulations
were performed and the second constriction was evaluated
for receptor-independent response.
Receptor-mediated vessel tone was measured as the
contractile response to 0.3 mol/L phenylephrine. Vessel Pone development is expressed as developed force relative
o wall length.10 Relaxation responses toward acetylcholine
10–9.0 to 10–4.5 mol/L) and sodium nitroprusside (10–10.0
o 10–4.0 mol/L) stimulation were tested after pre-
onstriction was induced with phenylephrine to assess
ndothelium-dependent and endothelium-independent
elaxations, respectively. These measurements were only
erformed for vessels with a sufficient preconstruction
0.02 mN/mm). Also tested were responses to 11,12-
poxyeicosatrienoic acid (leukotriene response, 10–8.0 to
0–6.0 mol/L) and prostaglandin E2 (prostaglandin re-
ponse, 10–10.0 to 10–6.5 mol/L).
To evaluate the effects on different pathways, inhibitors
ere added 10 minutes before preconstriction with phen-
lephrine and dose-response curves with acetylcholine were
erformed. Inhibitors used for the following targets were
ndothelial nitric oxide synthases (eNOS): 100 mol/L
G-Methyl-L-arginine acetate salt (L-NMMA); neuronal
OS (nNOS)/inducible NOS (iNOS): 50 mol/L 1-(2-
rifluoromethylphenyl)imidazole (TRIM); cyclooxygen-
se (COX): 1 mol/L indomethacin; thromboxane A2/
rostaglandin H receptor: 1 mol/L SQ29548; small and
ntermediate conductance calcium-gated potassium chan-
els: combination of apamin (50 nmol/L) and charyb-
otoxin (50 nmol/L); potassium adenosine triphosphate
KATP) channels: 3 mol/L glibenclamide.
Morphologic analysis of aorta cross-sections. To
heck for major morphologic alterations, aortic segments
tored 2 hours or 2 days at 4°C in TiProtec solution and
onstored controls (n 4 each) were fixed in formalin and
mbedded in paraffin. Cross-sections (4 m) were stained
ccording to elastica van Giessen and picro Sirius red stan-
ard protocols and examined under a light microscope to
ssess loss or disruption of elastic fibers and connective
issue, respectively. Smooth muscle cell organization was
hecked by immunohistochemistry using antimouse -
ctin antibody (Abcam, Cambridge, UK).
RNA isolation, microarray, and real-time reverse
ranscription polymerase chain reaction. After the re-
pective storage duration, vessels were placed in RNAlater
olution (Ambion GmbH, Darmstadt, Germany) and snap-
rozen in liquid nitrogen. Warm control vessels were dis-
ected in RNAlater solution. RNA was isolated by the
eqGOLD TriFast kit (Peqlab, Erlangen, Germany) ac-
ording to the manufacturer’s standard protocol, with one
xception: a double chloroform extraction was necessary to
btain sufficient RNA purity.
Alterations on the molecular level were evaluated by
uantitative real-time reverse transcription polymerase
hain reaction (RT-PCR; n  6-8). For this purpose RNA
as treated with DNaseI (Promega, Mannheim, Germany)
o remove residual DNA and reverse transcribed with
evertAid HMinus First Strand cDNA Synthesis kit
Fermentas, St. Leon-Rot, Germany) using oligodT.
eal-time RT-PCR was performed using the iCycler IQ
eal Time PCR System (Bio-Rad, Hercules, Calif) and
YBR Premix ExTaq II (Lonza AG, Cologne, Germany).
CR conditions for all primer sets (Table I) were as
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Volume 56, Number 1 Ebner et al 191follows: 95°C for 2 minutes, followed by 40 amplifica-
tion cycles, each consisting of 95°C for 20 seconds, 58°C
for 45 seconds, 72°C for 20 seconds, and 76°C for 5
seconds, with a final extension step at 72°C for 2 min-
utes. Identity of PCR products was proved by melting
point analysis and electrophoresis of the resulting PCR
fragment. TATA binding factor (Tbp) and polymerase
RNAII polypeptide A (Polr2A) served as housekeeping
genes.
Data analysis and statistics. Vascular tone and vessel
relaxation parameters were calculated as described previ-
ously.11 Vascular tone is given as developed force relative to
segment wall length. Maximum relaxation was expressed as
the percentage of phenylephrine constriction. Here, a di-
rect comparison was only possible for groups with similar
Table I. Primer for quantitative real-time reverse-transcrip
Gene Sense primer
Acaa1 TTGCAAGTCAGGCCGTC
Adipoq GAGATGCAGGTCTTCTT
AplnR GCACCTGCATCAGTTAT
ApoCI TGAGGCTCTTCATCGCT
C1qa GGCAATCCAGGCAATAT
Car3 ATGACAGGTCTATGCTG
CD36 GATTAATGGCACAGACG
Ces3 TGCTGGTCTGGTTGCTA
CfD ACTGCATGGATGGAGTG
Chchd10 ACAATCACGGTCTGAGC
Cox7a1 CTTCCAGGCCGACAATG
Cox8b GTCTCTGCCAAGCCAGC
Dbp ACCGCGCAGGCTTGAC
Dgat2 GCCATGGAGCTGATCTG
Dnm3os GTGCAGGAAGACAGGC
Fabp4 GGTGAAGAGCATCATAA
Hp GGTCCAGCCTATCTTGA
Jun ACGACCTTCTACGACGA
JunB ACGGCCACCATCAGCTA
mAldn1a7 GCTGGCTACAATGGAAT
mElovl6 CCGAACTAGGTGACACG
mGPR34 TAATGTGGCTGTTGCAG
mLyve1 ACAACTCATCCGACACC
mNfkbiz CGTGAATGCCAAGGCTT
mOtop1 CCAACAGCGTCCTGAAT
mPck1 GGTGTCATCCGCAAGCT
mPrkar2b CCAAGGTGATGACGGTG
Mrap GCATCAGCTGGCCTCAC
Orm1 GAGTACAGGCAGGCAAT
P2y12 GATTCAGCAGAACCAGG
Pde4b GGTGATTGACATGGTGT
Polr2a TCGAGCAGATCAGCAAG
Pon1 ACTTCTGCCTAGCATCA
PtgER3 GGTCGCCGCTATTGATA
Retn CAGTCTTGAGCTGCTCC
Rnpc3 TTGGACCGATTACTGCA
Scd1 CCTTCCTCCTGAATACA
Slc16a4 CTGCCAGTATTGGTTGA
Slc36a2 GCCACTGGTAGCAAGCT
Tbp CTCTGGAATTGTACCGC
Thrsp CGGAACATGGAGCAGG
Timp4 ACTCGGCTCTAGTGATA
Tmem45b GTCAGCAGGAGCGCAT
Ucp1 TACCAAGCTGTGCGATGpreconstriction. The half-maximum effective dose (EC50) Das calculated from sigmoidal-fitted dose-response curves
ith Sigma Plot 10.0 software (Systat Software Inc, Chi-
ago, Ill). Data are presented as mean the standard error
f the mean.
Data were analyzed for normal distribution with
olmogorov-Smirnov test. Homogeneity of variances was
ssessed according to Levene. Intergroup differences were
ested using one-way analysis of variance. Differences were
ssessed with post hoc multiple comparisons. A value ofP
05 was taken to indicate a significant difference. Data
nalysis was performed using SPSS 11.5 software (SPSS
nc, Chicago, Ill).
For quantitative PCR analysis, relative expression was
alculated by 2–Ct methods using geometric average cal-
ulation to normalize for multiple housekeeping genes.13
polymerase chain reaction analysis
Antisense primer
GTGACAACCTGCCTTGCTCC
CGATACACATAAGCGGCTTC
CTGATCACAGCAGAGCATGG
CCGGTATGCTCTCCAATGT
AGATAACCACGTTGCCAAGC
TGCTCAGAGCCGTGGTCATC
GAACACAGCGTAGATAGACC
GTCTCCAGTAGTTCATCCTC
CTGCACATCATACCATCGCT
GAACGATCCTTCCTTACTCC
GCAGTATAAGCAGTAGGCAG
CATCCTGCTGGAACCATGA
TTGGTTGAGGCTTCAGTTCC
CTCGGCCATGGAAGATGC
GTCCTGAACAGGTAGTCTGA
CCAGCTTGTCACCATCTCGT
GTCCTCCTCCATGTCATGAA
GCCAGGTTCAAGGTCATGCT
TACGGTCTGCGGTTCCTCTT
CAGCCTGCGAAGTACTGTAA
ACCAGGAGTACAGGAGCACA
TCACACCTAGTGTCCACTTG
GGATGAAGCCAAGTAGG
CTGCGTCCAACTGTGTCACC
CACTGTGGTGTGTGGTCATC
CTGTGTCTCTCTGCTCTTGG
TAGTTACCGACGCATCTTCC
CGACTGGCTCTCTGGCATCA
CCGAAGCTCTATTGTGTCGT
GCCAAGCTGTTCGTGATGAG
GAGGAGAACACCGGAGCTTG
CAATGCCCAGTACCGTGAAG
ACATTGGACCACGACAGACC
GAATTGCACTCCTTCTCC
GCTGCTGTCCAGTCTATCCT
CCTCATCCTCATCTGGTAAG
CTGCAGTGAACTTCATCAGC
CTGCTATTGGTGGTCCAGAA
AGAGGCAGGACCACACCGAT
CGCAGTTGTCCGTGGCTCTC
T CTTGAGCATGGTGAAGTAGG
ATCCTTGGCCTTCTCGAACC
GGTGAGGTCCATCTGGAACA
GGTACAATCCACTGTCTGTCtion
TAC
G
GTC
CTT
CAG
AGG
CAG
CTC
ACG
TCC
ACC
CAA
AT
TCTC
CC
ACG
TGC
CCT
C
ATA
ACC
TG
AC
GAA
GAA
ACA
ACT
TCA
ACC
TGG
GTG
ACG
ATG
TGT
CG
TCC
CCT
GGA
AGC
TGG
CG
TGAGata were standardized to a heart tissue standard.
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Vascular function of mouse aorta after cold storage.
Cold storage at 4°C for 2 days significantly impaired
function of mouse aorta. This was evident with respect to
vessel tone development induced by a high potassium
concentration as well as with respect to maximum vessel
relaxation induced by acetylcholine and nitroprusside (Fig
1). Initially, a significant increase in vascular tone devel-
opment was evident after 1 day of cold storage. Whether
this may be attributed to recovery from the surgical
trauma remains unclear at the present. After 7 days of
cold storage, no preconstriction with phenylephrine was
possible. Therefore, a subsequent relaxation analysis was
not performed.
Endothelium-dependent vessel relaxation: Nitric
oxide. The response toward acetylcholine is regarded an
endothelium-dependent response because acetylcholine
leads to a release of mediators from the endothelial cell
layer, which in turn activate potassium channels that
trigger smooth muscle relaxation.14 In mouse aorta,
vessel relaxation in response to acetylcholine is mostly
mediated via nitric oxide release from eNOS, because
only a small residual relaxation is observed in presence of
L-NMMA (Fig 2, A). Presence of TRIM, an inhibitor of
neuronal and inducible nitric oxide synthase (nNOS and
iNOS) did not alter the maximum relaxation response of
Fig 1. Vessel function after cold storage at 4°C in an op
for 2 hours. Cold storage for 2 days significantly im
constriction and acetylcholine as well as nitroprusside-ind
bars show the standard error of the mean.acetylcholine. mThe maximum relaxation response was not significantly
educed in presence of L-NMMA, although a trend (P 
20) for reduction was obvious. The presence of L-NMMA
nfluenced the relaxation sensitivity, calculated as the EC50
alue. A significant shift of the dose-response curve to the
ight was observed, indicating an influence on relaxation
ensitivity. This shift was significantly more pronounced in
essels stored for 2 days at 4°C (Fig 2, B).
Endothelium-dependent vessel relaxation: Arachi-
onic acid products. Arachidonic acid is metabolized by
OX to a variety of vasoactive substances, including pros-
acyclin, prostaglandin E2, or thromboxane A2.
15 Prosta-
landin E2 only induced a small relaxation response in very
ow concentration (3 nmol/L) in mouse aorta (Fig 1).
his relaxation response was nearly completely abolished
fter 2 days of cold storage.
Indomethacin inhibition of COX activity does not alter
aximum acetylcholine-induced relaxation (Fig 2, A).
owever, the dose-response curve in presence of indo-
ethacin was significantly shifted to the right for both
torage conditions (Fig 2, B), indicating reduced relaxation
ensitivity and therefore a minor contribution of COX
roducts to acetylcholine-induced relaxation.
Endothelium-dependent vessel relaxation: Endo-
helial cell hyperpolarization factor. Apart from nitric
xide and COX products, acetylcholine-induced relaxation
ed storage solution. Control vessels (0 days) were stored
vascular function with respect to potassium-induced
relaxation compared with control conditions. The errortimiz
pairs
uceday be mediated by a chemically unidentified stimulus
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Volume 56, Number 1 Ebner et al 193termed “endothelial cell hyperpolarization factor,” which is
defined to be the endothelium-dependent relaxation re-
sponse persisting block of eNOS and COX.16 In the com-
bined presence of L-NMMA and indomethacin (I	L), no
impairment of the minimal residual relaxation by cold
storage was observed (Fig 2, A), and EC50-values were
similar (P  .516; Fig 2, B). In addition, the relaxation
response toward 11,12-EET, a putative endothelial cell
hyperpolarization factor mediator,17 resulted only in a
small contribution to relaxation (10.8%  2.0%), and this
relaxation response was not significantly altered by pro-
longed cold storage (10.8%  1.7%).
Endothelium-dependent vessel relaxation: Potas-
sium channels. Subsequent smooth muscle relaxation is
mediated via ATP-gated potassium channels (KATP,
blocked by glibenclamide) and calcium-activated potas-
sium channels (KCa, blocked by apamin plus charyb-
dotoxin). Impairment of acetylcholine-dependent vessel
relaxation after 2 days of cold storage was observed in the
Fig 2. Contributions of different endothelium-derived
ation: (A) maximum relaxation, (B) relaxation sensitivity
aorta vessel is mostly mediated via nitric oxide synthase si
the presence of L-NG-monomethyl arginine (L-NMMA).
not alter maximum relaxation. In the combined presenc
residual relaxation by cold storage was observed. The errpresence of glibenclamide (Fig 3), but not in the combined mresence of charybdotoxin and apamin. This indicates that
he relaxation mechanisms that are impaired by 2 days of
old storage in mouse aorta mediate their relaxation via KCa
hannels.
Acetylcholine-dependent vessel contraction. Mouse
orta displays a biphasic response to acetylcholine (Fig 4,
eft panel), as others have described.18 In low concentra-
ions (0.3 mol/L), acetylcholine induced relaxation of
reconstricted vessels; in higher concentrations (1 to 10
mol/L), acetylcholine caused slight vasoconstriction (Fig
). This vasoconstriction is significantly (P .042) reduced
n aorta segments stored for 2 days (8% 2%) compared with
egments stored for 2 hours (18%  5%). Acetylcholine-
nduced vasoconstriction is blocked by inhibitors of nNOS/
NOS (TRIM), thromboxane A2/prostaglandin H-receptor
SQ29458), or COX (indomethacin).
Morphologic alterations by prolonged cold storage.
ross-sections were stained to assess elastic fibers and con-
ective tissue to judge major morphologic damage, which
iators to acetylcholine (ACH)-dependent vessel relax-
-maximum effective dose [EC50]). Relaxation in mouse
g, because only a small residual relaxation is observed in
bition of cyclooxygenase by indomethacin (INDO) does
indomethacin and L-NMMA (I	L), no impairment of
rs show the standard error of the mean.med
(half
gnalin
Inhi
e ofay influence vessel tone development (Fig 5). Despite the
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July 2012194 Ebner et alsignificantly impaired function (see above), neither loss nor
disruption of connective tissue or elastic fibers was found
after 2 days of cold storage.
PCR analysis. Microarray analysis (Appendix, online
only) revealed that 36 annotated genes were significantly
altered by more than threefold. These and additionally
phosphodiesterase 4b (Pde4b), purinergic receptor (P2y12),
tissue inhibitor of metalloproteinases 4 (Timp4), D site
albumin promoter binding protein (Dbp), complement
factor 1 (C1qa), and JunB oncogene were analyzed by
quantitative real-time RT-PCR for validation of microarray
Fig 4. Acetylcholine-dependent vessel tone modulation
acetylcholine (ACH). In low concentration (10 to 6
concentrations (10 to 6), relaxation ceases and turns tow
vasoconstriction (expressed as percentage of phenylephri
response is blocked by inhibitors of neuronal and in
Fig 3. Contributions of different potassium channel types to
acetylcholine (ACH)-dependent vessel relaxation: Impairment of
acetylcholine-dependent vessel relaxation was observed in the pres-
ence of the adenosine triphosphate-dependent potassium channel
inhibitor glibenclamide (GC) but not in the combined presence of
charybdotoxin and apamin (A	C), inhibitors of large and inter-
mediate calcium-sensitive potassium channels. The error bars show
the standard error of the mean.prostaglandin H receptor (SQ29548), or cyclooxygenase (INDesults. For RNA analysis, it was methodically possible to
ntroduce a warm control group (no cold injury or contact
ith the storage solution) that served as a nondamaged
ontrol. Quantitative RT-PCR showed that 24 genes were
ignificantly changed due to cold storage. Results are sum-
arized alphabetically in Table II. Most genes, with the
xception of stearoyl-coenzyme A desaturase 1 (Scd1),
elanocortin two-receptor accessory protein (Mrap), lym-
hatic vessel endothelial hyaluronan receptor 1 (Lyve1),
nd JunB oncogene were altered significantly even within
he first 2 hours of cold storage.
ISCUSSION
Mouse models are frequently used for research pur-
oses because they are cheap, well characterized, and offer
nique possibilities due to the availability of a variety of
enetically modified strains.19 Murine models of vessel
ransplantation studies usually use the thoracic aorta.20 The
resent study characterizes cold storage injury of mouse
orta on functional and molecular levels.
Application of sodium nitroprusside, a compound di-
ectly releasing nitric oxide, results in a complete relaxation
f phenylephrine preconstriction, and this response was
ignificantly reduced after 2 days of cold storage. This
ndicates failure of nitric oxide signaling downstream of
itric oxide release from endothelial cells. Approximately
2% of a preconstriction with phenylephrine can be relaxed
sing acetylcholine. The nitric oxide-mediated part of the
cetylcholine response can be estimated by subtraction of
he residual relaxation in presence of L-NMMA from con-
rol relaxation. This was in the same range for vessels stored
hours (54%  4%) and for segments stored for 2 days
54%  3%). Therefore, impaired eNOS signaling is un-
ikely to be the reason for impaired acetylcholine relaxation.
Combined application of L-NMMA and indomethacin
educed the mean maximum relaxation by 4% after 2 hours
f cold storage and significantly lowered the relaxation
ensitivity compared with the application of L-NMMA
t panel, Mouse aorta displays two distinct responses to
CH is able to relax a preconstricted vessel; in higher
asoconstriction. Right panel, ACH-induced maximum
constriction) is impaired by 2 days of cold storage. This
le nitric oxide synthase (TRIM), thromboxane A2/. Lef
.5), A
ard v
ne pre
ducibO). The error bars show the standard error of the mean.
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Volume 56, Number 1 Ebner et al 195alone. This was not the case after 2 days of cold storage,
suggesting an involvement of COX products in cold stor-
age injury. This finding supports the hypothesis that the
minimal relaxation response toward prostaglandin E2 and
the acetylcholine-mediated constriction are reduced after 2
days of cold storage. Evidence from the current study and
work from others shows that this vasoconstriction is medi-
ated by superoxide radicals or COX products, or both, that
Fig 5. Staining with (top) picro-Sirius red and (middl
chemistry of aorta cross-sections shows no loss or disrupt
fiber (black-lilac in the middle panel) was induced by prol
disturbed. Original magnification was 100
 for overvieware released from the endothelium of mouse aorta.18 cThis leaves the question of which downstream effects of
itric oxide signaling (sodium nitroprusside response) are
mpaired. Downstream relaxation mechanisms may include
ctivation of ATP-dependent or calcium-gated potassium
hannels, or both.21 In the present study, approximately
ne-third of the acetylcholine response was blocked in
resence of glibenclamide, an inhibitor preferentially affect-
ng K channels, and two-thirds were blocked by the
stica van Giessen, and (bottom) -actin immunohisto-
f connective tissue (red in the top panel) and that elastic
d cold storage. Smooth muscle cell organization was not
ures and 400
 for zoom views.e) ela
ion o
ongeATP
ombined presence of apamin and charybdotoxin. The
e
d
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m
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bined presence of apamin and charybdotoxin is therefore
mediated through KATP-channels, and this response is not
impaired by cold storage. Under block of KATP-channels,
the residual relaxation was significantly lower after 2 days of
Table II. Results for polymerase chain reaction validation
Gene symbol Gene title F
Adipoq Adiponectin Adipokin
ApocI Apolipoprotein C-I Uptake an
VLDL
particle
Car3 Carbonic anhydrase 3 EC 4.2.1
anhydr
CD36 CD36 antigen Transmem
(variou
Cfd Complement factor D EC 3.4.2
proteas
Cox8b Cytochrome-c oxidase subunit
VIIIb
EC 1.9.3
electron
Dbp D site albumin promoter binding
protein
Transcrip
Dgat2 Diacylglycerol O-acyltransferase 2 EC 2.3.1
final ste
triacylg
Elovl6 ELOVL family member 6 Elongatio
fatty ac
Fabp4 Fatty acid binding protein 4 Regulates
traffick
fatty ac
Jun Jun oncogene Regulator
Lyve1 Lymphatic vessel endothelial
hyaluronan receptor 1
Hyaluron
Mrap Melanocortin 2 receptor accessory
protein
Traffickin
of mela
recepto
Otop1 Otopetrin 1 Mineraliz
Pck1 Phosphoenolpyruvate
carboxykinase 1, cytosolic
EC 4.1.1
phosph
carboxy
Pon1 Paraoxonase-1 EC 3.1.1
glucon
Prkar2b Protein kinase, cAMP dependent
regulatory, type I
Fibroblas
regulat
Ptger3 Prostaglandin E receptor 3 Mediation
vasocon
Retn Resistin Adipokin
Scd1 Stearoyl-coenzyme A desaturase 1 EC 1.14.
metabo
Slc36a2 Solute carrier family 36, member 2 Proton/a
sympor
Thrsp Thyroid hormone responsive
SPOT14 homolog
Expressed
stimula
Tmem45b Transmembrane protein 45b Unknown
Ucp1 Uncoupling protein 1 Mitochon
carrier;
electron
cAMP, Cyclic adenosine monophosphate; HDL, high-density lipoprotein; V
aRelative expression was normalized to housekeeping genes Tbp and Polr2A
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Volume 56, Number 1 Ebner et al 197To characterize cold storage injury in mouse aorta on a
molecular level, we performed microarray analysis and val-
idated the results by real-time RT-PCR. Various genes were
altered significantly, even within the first 2 hours of cold
storage. This is of major importance because of the time
delay between alterations on messenger RNA and the func-
tional level. This means that regulation on the molecular
level may occur before any alterations on the morphologic
or functional level develop. This may be of utmost impor-
tance for peripheral or coronary artery bypass grafting,
where vessel segments are stored for intervals of 2 hours.
After 2 hours of cold storage, vascular function is not
reduced compared with warm controls (acetylcholine relax-
ation warm control, 61%; cold storage, 60%).
RNA expression of various genes was significantly al-
tered within this narrow time frame, however, and some of
these targets likely have implications for later graft function.
For example, protein kinase A regulatory subunit-
(Prkar2b) can regulate fibroblast growth and apoptosis,
depending on the presence of thyroid-stimulating hor-
mone.23 Furthermore, Prkar2b is involved in suppression
of balloon injury-induced neointimal hyperplasia.24 An-
other example is prostaglandin E3 receptor, which is known
to mediate and potentate vasoconstriction in rat vessels.25
Fatty acid binding protein 4 (Fabp4) regulates intracellular
trafficking of long-chain fatty acids, and significantly higher
expression has been described in the aortic tissue of patients
with metabolic syndrome and severe coronary artery occlu-
sion than in patients with a normal body mass index and
aortic stenosis.26
Expression in the vascular system of other targets has
not been described before, but their function in other
tissues may link them to cold storage injury of mouse aorta.
Uncoupling protein 1 (Ucp1) is a mitochondrial proton
carrier that mediates brown adipose tissue hypoxia in re-
sponse to hypothermia.27 Carbonic anhydrase 3 (Car3)
protects against radical injury that is induced by hydrogen
peroxide (H2O2).
28 These Fenton-type reactions of H2O2
are crucially involved in cold storage injury in the absence of
respective protective substances.29 Some have speculated
that Car3 is actually not a carbonic anhydrase (H2O	CO2
¡H2CO3) but a percarbonic anhydrase (H2O2	 CO2¡
H2CO4) and therefore directly degrades H2O2.
30
Adiponectin (Adipoq) and resistin (Retn) are adipo-
kines that are associated with the outcome of peripheral
revascularization.31 Adipsin (complement factor D [CfD])
is a serine protease involved in the alternative pathway
of complement immune response.32 Diacylglycerol O-
acyltransferase 2 (Dgat2) catalyses the final step of triacyl-
glycerol synthesis and therefore crucially regulates triglyc-
eride content in liver33 and very low-density lipid proteins
(VLDL) triglyceride content.34 This may be of importance
for hypertriglyceremia-induced atherosclerosis. Apolipo-
protein C1 (ApoCI) is a potent inhibitor of hepatic uptake
of VLDL particles and inhibits triglyceride hydrolysis.35
Furthermore, ApoC1 regulated HDL lipid composition
and elevated LSP-induced inflammatory response and ath-rosclerotic lesion formation at the aortic root of ApoE-
eficient mice.36
Which of these genes determines graft quality and
atency remains to be established. For many of these mo-
ecular targets (eg, secreted factors such as adiponectin,
esistin, adipsin, and ApoC1), a direct functional implica-
ion of local expression changes for the vascular system has
ot been described. To date, only systemic functions have
een documented, and production of these compounds by
he graft tissue after altered expression may interact with
hat provided from other sites of production. For some of
he targets (eg, Tmem45b), no function at all has been
escribed to date.
Taken together, we demonstrate that cold storage of
ouse aorta for 2 days results in a decline of vasorelaxation
nd stimulus-induced vasoconstrictor function. This dys-
unction includes endothelial-dependent and smooth
uscle-dependent pathways and is paralleled by alteration
f various genes. Strikingly, many of the alterations ob-
erved on the molecular level occur within the first 2 hours
f storage and may influence later graft function. The
unctional changes appear 2 days of cold storage yet
ithout significant alterations of vessel structure.
ONCLUSIONS
Further studies are needed to evaluate the target–
unction relationship for each altered gene and elucidate
he role of these targets for vascular function and graft
atency after implantation. In addition, the exact onset of
he observed alterations on molecular level needs to be
nalyzed in more detail in graft-relevant human vessel
odels. Furthermore, whether the disturbance in one of
he molecular structures affects cold storage sensitivity re-
ains to be investigated. This would be of particular inter-
st for comorbidities that are associated with impaired
ascular function.
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Methods. Fat-free mouse aortas stored for 2 hours
(n  3) or 2 days (n  3) at 4°C were studied. After the
respective storage duration, vessels were placed in RNAl-
ater solution (Ambion). RNA was isolated by PeqGOLD
TriFast kit (Peqlab) according to the manufacturer’s stan-
dard protocol with one exception: a double chloroform
extraction was necessary to obtain sufficient RNA purity.
Affimetrix whole mouse genome microarray analysis was
performed at the microarray core facility of Max Planck
Institute for Cell Biology and Molecular Genetics, Dres-
den, according to the manufacturer’s instructions.
Data evaluation of the microarray analysis was per-
formed according to manufacturer’s suggestions using
GeneSpring 
 6 11.01 software (Agilent Technologies,
Santa Clara, Calif). Data were compared as normalized
quartiles. The 20% lowest expressed genes and mismatch
genes were excluded from analysis; only genes with at least
three valid measurements of the six analyzed samples mea- (ured were included. A value of P  .05 and at least a
wofold change was considered significant.
Results. Microarray analysis was performed for three
amples each of mouse aorta stored 2 hours or 2 days at 4°C
n an optimized storage solution and revealed 118 signifi-
antly and more than twofold altered genes, of which 82
ere annotated. These genes included 14 upregulated
enes, and 68 of the significantly altered annotated genes
ere downregulated (Table III, online only). Gene ontol-
gy metabolic pathway analysis was performed. No clear
icture on one specifically targeted pathway was observed,
ut a broad variety of genes that are known to be involved
n many different metabolic functions were seen. Some of
hese pathways may be involved in the regulation of vascu-
ar function; for example, smooth muscle contraction
Pde4b, Rgs18, Prkar2b, Jun), prostaglandin synthesis and
etabolism (Hpgd, Endrb, Ptger3), calcium regulation
Prkar2b, Adr3b, Rgs18), or electron transport chain
Ucp1, Cox8b, Cox7a1, Atp5ca).
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Gene symbol Gene title Fold change P
Upregulated genes
Jun Jun oncogene 3.3 .001
Nfkbiz INAP messenger RNA for IL-1 inducible nuclear ankyrin-
repeat protein
3.0 .001
JunB JunB oncogene 2.9 .001
Nr1d1 Nuclear receptor subfamily 1, group D, member 1 2.5 .013
Dbp D site albumin promoter binding protein 2.5 .042
Hist1h1e Histone cluster 1, H1e 2.4 .005
BtgI B-cell translocation gene 1, antiproliferative 2.2 .001
Trio Triple functional domain (PTPRF interacting) 2.2 .006
Pde4b Phosphodiesterase 4B, cAMP specific 2.2 .004
Gadd45g Growth arrest and DNA-damage-inducible 45 gamma 2.1 .001
Timp4 Tissue inhibitor of metalloproteinase 4 2.1 .010
Picalm Phosphatidylinositol binding clathrin assembly protein 2.1 .005
Fam107a Family with sequence similarity 107, member A 2.1 .050
Fosb FBJ osteosarcoma oncogene B 2.0 .047
Gene symbol Gene title Absolute fold change P
Downregulated genes
Ucp1 Uncoupling protein 1 (mitochondrial, proton carrier) 9.1 .001
Ces3 Carboxylesterase 3 7.9 .002
Adipoq Adiponectin, C1Q and collagen domain containing 7.8 .009
Cox8b Cytochrome-c oxidase, subunit VIIIb 7.1 .002
Car3 Carbonic anhydrase 3 6.9 .008
Thrsp Thyroid hormone responsive SPOT14 homolog (Rattus) 6.9 .001
Dnm3os Dynamin 3, opposite strand 6.7 .001
Cfd Complement factor D (adipsin) 6.5 .014
Tmem45b Transmembrane protein 45b 5.2 .004
CD36 CD36 antigen 5.1 .004
Hp Haptoglobin 4.9 .016
Cox7a1 Cytochrome-c oxidase, subunit VIIa 1 4.9 .001
Fabp4 Fatty acid binding protein 4, adipocyte 4.7 .005
Aldh1a7 Aldehyde dehydrogenase family 1, subfamily A7 4.5 .005
Orm1 Orosomucoid 1 4.2 .001
Slc16a4 Solute carrier family 16 (monocarboxylic acid transporters),
member 4
4.0 .001
Prkar2b Protein kinase. cAMP dependent regulatory, type II beta 4.0 .005
Otop1 Otopetrin 1 3.8 .012
ApocI Apolipoprotein C-I 3.8 .008
Scd1 Stearoyl-coenzyme A desaturase 1 3.6 .012
Rnpc3 RNA-binding region (RNP1, RRM) containing 3 3.6 .001
Slc36a2 Solute carrier family 36 (proton/amino acid symporter),
member 2
3.5 .007
Ptger3 Prostaglandin E3 (subtype EP3) 3.4 .001
Pck1 Phosphoenolpyruvate carboxykinase 1, cytosolic 3.4 .030
Retn Resistin 3.3 .018
Aplnr Apelin receptor 3.3 .007
Mrap Melanocortin 2 receptor accessory protein 3.2 .003
Dgat2 Diacylglycerol O-acyltransferase 2 3.1 .003
Pon1 Paraoxonase-1 3.1 .031
Gpr34 G protein-coupled receptor 34 3.1 .008
Chchd10 Coiled-coil-helix-coiled-coil-helix domain containing 10 3.0 .001
Acaa1b Acetyl-CoA acyltransferase 1B 3.0 .008
Lyve1 Lymphatic vessel endothelial hyaluronan receptor 1 3.0 .022
Elovl6 ELOVL family member 6 (elongation of long chain fatty acids
[yeast])
3.0 .001
Gas5 Growth arrest specific 5 2.9 .001
Ednrb Endothelin receptor type B 2.9 .032
Fubp1 Far downstream element (FUSE) binding protein 1 2.9 .002
Fasn Fatty acid synthase 2.8 .001
Gpd1 Glycerol-3-phosphate dehydrogenase 1 (soluble) 2.8 .002
CD163 CD163 antigen 2.7 .048
C1qa Complement component 1, q subcomponent. Alpha 2.6 .047polypeptide
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Gene symbol Gene title Fold change P
Cidec Cell death-inducing DFFA-like effector c 2.6 .047
Pcx Pyruvate carboxylase 2.5 .007
Acss2 Acyl-CoA synthetase short-chain family member 2 2.5 .001
Cyp2f2 Cytochrome P450, family 2, subfamily f.
polypeptide 2
2.4 .035
Rbm3 RNA binding motif protein 3 2.4 .013
Adrb3 Adrenergic receptor, beta 3 2.4 .013
Clec4a3 C-type lectin domain family 4, member a3 2.4 .004
St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2.8-
sialyltransferase 4
2.4 .005
Ccr5 Chemokine (C–C motif) receptor 5 2.4 .007
Hpgd Hydroxyprostaglandin dehydrogenase 15 (NAD) 2.4 .027
Rbmx RNA binding motif protein, X chromosome 2.4 .002
Chd2 Chromodomain helicase DNA binding protein 2 2.3 .001
Ttc14 Tetratricopeptide repeat domain 14 2.3 .001
Agpat2 1-Acylglycerol-3-phosphate O-acyltransferase 2 2.3 .001
Fcgr2b Fc receptor, immunoglobulin G, low affinity IIb 2.3 .033
Prei4 Preimplantation protein 4 2.3 .001
Atp5c1 ATP synthase, H	 transporting; mitochondrial
F1 complex, gamma polypeptide 1
2.3 .001
Xpa Xeroderma pigmentosum, complementation
group A
2.3 .001
Slc16a1 Solute carrier family 16 (monocarboxylic acid
transporters), member 1
2.3 .002
Emr1 EGF-like module containing. Mucin-like,
hormone receptor-like sequence 1
2.3 .015
Rprd1a Regulation of nuclear pre-mRNA domain
containing 1A
2.3 .001
Cd1d1 CD1d1 antigen 2.3 .010
Dleu2 Deleted in lymphocytic leukemia, 2 2.2 .002
C3ar1 Complement component 3a receptor 1 2.2 .018
Ms4a6d Membrane-spanning 4-domains, subfamily A,
member 6D
2.2 .040
Mgl2 Macrophage galactose N-acetyl-galactosamine
specific lectin 2
2.2 .039
Pstk Phospho seryl-tRNA kinase 2.2 .001
Lipe Lipase, hormone sensitive 2.2 .001
Ccl9 Chemokine (C-C motif) ligand 9 2.2 .043
Malat1 Metastasis associated lung adenocarcinoma
transcript 1 (noncoding RNA)
2.1 .005
RGS18 Regulator of G protein signaling 18 2.1 .015
Pus3 Pseudouridine synthase 3 2.1 .005
Tardbp TAR DNA binding protein 2.1 .001
Acly ATP citrate lyase 2.1 .001
Cidea Cell death-inducing DNA fragmentation factor,
alpha subunit-like effector A
2.1 .018
Zfp207 Zinc finger protein 207 2.1 .006
Gpihbp1 GPI-anchored HDL-binding protein 1 2.1 .002
P2ry12 Purinergic receptor P2Y, G-protein coupled 12 2.0 .007
Zfp58 Zinc finger protein 58 2.0 .025
CD53 CD53 antigen 2.0 .011
Cebpa C/EBP, alpha 2.0 .003
Mirhg1 microRNA host gene 1 2.0 .009
Rbbp6 Retinoblastoma binding protein 6 2.0 .010
Lyz2 Lysozyme 2 2.0 .045
F13a1 Coagulation factor XIII, A1 subunit 2.0 .041
ATP, Adenosine triphosphate; cAMP, cyclic adenosine monophosphate; C/EPB, cytidine-cytidine-adenosine-adenosine-thymidine enhancer-binding pro-
teins; CoA, coenzyme A; GPI, glycosylphosphatidylinositol; EGF, endothelial growth factor; HDL, high-density lipoprotein; IL, interleukin; INAP, inducible
nuclear ankyrin-repeat protein.
